Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125706601 | 12570660 | 1 | I | 201605 | 20160711 | 20160719 | 20160719 | PER | US-PFIZER INC-2016340065 | PFIZER | 71.00 | YR | F | Y | 60.00000 | KG | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125706601 | 12570660 | 1 | PS | Genotropin MQ | SOMATROPIN | 1 | 0.2 MG, 1X/DAY (BEFORE BEDTIME INJECTION) | M18868 | 20280 | .2 | MG | POWDER FOR SOLUTION FOR INJECTION | QD | ||||||
| 125706601 | 12570660 | 2 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 250 MG (500MG 1/2 TABLET), 1X/DAY | 0 | 250 | MG | TABLET | QD | |||||||
| 125706601 | 12570660 | 3 | C | ARMOUR THYROID | THYROID, PORCINE | 1 | 120 MG, DAILY | 0 | 120 | MG | |||||||||
| 125706601 | 12570660 | 4 | C | AVAPRO | IRBESARTAN | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | QD | ||||||||
| 125706601 | 12570660 | 5 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 120 MG, DAILY | 0 | 120 | MG | |||||||||
| 125706601 | 12570660 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 12.5 MG, DAILY | 0 | 12.5 | MG | |||||||||
| 125706601 | 12570660 | 7 | C | ALDACTONE | SPIRONOLACTONE | 1 | 0.5 DF (1/2 HALF TABLET), DAILY | 0 | .5 | DF | TABLET | ||||||||
| 125706601 | 12570660 | 8 | C | ALDACTONE | SPIRONOLACTONE | 1 | 0 | TABLET | |||||||||||
| 125706601 | 12570660 | 9 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 8 MEQ, 1X/DAY | 0 | 8 | MEQ | TABLET | QD | |||||||
| 125706601 | 12570660 | 10 | C | DHEA SR | 2 | 20MG CAPS DAILY | 0 | 20 | MG | CAPSULE | |||||||||
| 125706601 | 12570660 | 11 | C | BioTE Iodine Plus | 2 | 12.5 MG, DAILY | 0 | 12.5 | MG | ||||||||||
| 125706601 | 12570660 | 12 | C | Biote DIM | 2 | 150 MG, DAILY | 0 | 150 | MG | CAPSULE | |||||||||
| 125706601 | 12570660 | 13 | C | VITAMIN A D | PETROLATUM | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 125706601 | 12570660 | 14 | C | VITAMIN K | PHYTONADIONE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 125706601 | 12570660 | 15 | C | OMEGA 3 KRILL OIL | 2 | 500 MG, 2X/DAY | 0 | 500 | MG | BID | |||||||||
| 125706601 | 12570660 | 16 | C | B COMPLEX PLUS | 2 | 2 DF, DAILY | 0 | 2 | DF | ||||||||||
| 125706601 | 12570660 | 17 | C | MAGNESIUM GLYCINATE | MAGNESIUM GLYCINATE | 1 | 2 DF, 2X/DAY (TWO IN MORNING AND TWO AT NIGHT) | 0 | 2 | DF | BID | ||||||||
| 125706601 | 12570660 | 18 | C | COENZYME Q10 | UBIDECARENONE | 1 | 200 MG, DAILY | 0 | 200 | MG | |||||||||
| 125706601 | 12570660 | 19 | C | PROBIOTICS | PROBIOTICS NOS | 1 | 300 MG, 2X/DAY | 0 | 300 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125706601 | 12570660 | 1 | Hypopituitarism |
| 125706601 | 12570660 | 2 | Diabetes mellitus |
| 125706601 | 12570660 | 3 | Thyroid disorder |
| 125706601 | 12570660 | 4 | Blood pressure abnormal |
| 125706601 | 12570660 | 5 | Depression |
| 125706601 | 12570660 | 6 | Fluid retention |
| 125706601 | 12570660 | 7 | Blood pressure abnormal |
| 125706601 | 12570660 | 8 | Blood triglycerides abnormal |
| 125706601 | 12570660 | 9 | Blood potassium decreased |
| 125706601 | 12570660 | 11 | Hormone replacement therapy |
| 125706601 | 12570660 | 12 | Hormone replacement therapy |
| 125706601 | 12570660 | 13 | Vitamin supplementation |
| 125706601 | 12570660 | 14 | Vitamin supplementation |
| 125706601 | 12570660 | 15 | Blood cholesterol abnormal |
| 125706601 | 12570660 | 17 | Constipation |
| 125706601 | 12570660 | 19 | Gastrointestinal disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125706601 | 12570660 | Asthenia | |
| 125706601 | 12570660 | Balance disorder | |
| 125706601 | 12570660 | Dehydration | |
| 125706601 | 12570660 | Dizziness | |
| 125706601 | 12570660 | Insomnia | |
| 125706601 | 12570660 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125706601 | 12570660 | 1 | 2004 | 201605 | 0 | |
| 125706601 | 12570660 | 2 | 2000 | 0 | ||
| 125706601 | 12570660 | 3 | 2011 | 0 | ||
| 125706601 | 12570660 | 5 | 2002 | 0 | ||
| 125706601 | 12570660 | 6 | 2006 | 0 | ||
| 125706601 | 12570660 | 7 | 2012 | 0 | ||
| 125706601 | 12570660 | 10 | 2015 | 0 | ||
| 125706601 | 12570660 | 11 | 2014 | 0 | ||
| 125706601 | 12570660 | 12 | 2014 | 0 | ||
| 125706601 | 12570660 | 13 | 2014 | 0 | ||
| 125706601 | 12570660 | 14 | 2014 | 0 | ||
| 125706601 | 12570660 | 15 | 2011 | 0 | ||
| 125706601 | 12570660 | 16 | 2015 | 0 | ||
| 125706601 | 12570660 | 17 | 2012 | 0 | ||
| 125706601 | 12570660 | 18 | 2015 | 0 | ||
| 125706601 | 12570660 | 19 | 2014 | 0 |